Status:
UNKNOWN
Exercise Response After Revalidation in Cancer Patients
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Oncology
Cardiac Toxicity
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study regarding oncological patients for rehabilitation after specific cancer therapy involves three aims: (1) to evaluate the predictive value of myocardial work parameters on the improvement of...
Detailed Description
Myocardial work (MW) provides an estimation of cardiac function by combining global longitudinal strain (GLS) with blood pressure values obtained non-invasively, being less load dependent than standar...
Eligibility Criteria
Inclusion
- Patients diagnosed with cancer
- Undergoing chemotherapy and/or radiotherapy/hormone therapy
- Age older than 18 years old - maximum age of 90 years old
- Willing to enter revalidation in Universitair Ziekenhuis Brussel
- Signed consent form
Exclusion
- Severe aortic stenosis defined as aortic valve aria under 0.6 cm2/m2
- Supraventricular arrhythmias
- Poor image quality for 2D and 3D echocardiography defined as the impossibility to examine of more than 2 adjacent segments
- Resistant hypertension defined as uncontrolled blood pressure values under current European guidelines, Systolic Blood Pressure more than 140 mmHg and/or Diastolic Blood Pressure more than 80 mmHg
- Lung cancer
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2022
Estimated Enrollment :
191 Patients enrolled
Trial Details
Trial ID
NCT04461392
Start Date
August 1 2020
End Date
August 1 2022
Last Update
July 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitair Ziekenhuis Brussel
Jette, Belgium, 1090